Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Furtner

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
Neuroimage. Clinical|September 25, 2020
High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSIGilbert Hangel, Cornelius Cadrien, Philipp Lazen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2024
Corrigendum to "Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial" [Eur J Cancer 198 (2024) 113475]Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patientsAngelika M Starzer, Anna S Berghoff, Rainer Hamacher, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Cancers|May 13, 2023
Proof-of-Concept for Liquid Biopsy Disease Monitoring of <i>MYC</i>-Amplified Group 3 Medulloblastoma by Droplet Digital PCRNatalia Stepien, Daniel Senfter, Julia Furtner, et al.
Acta Neuropathologica|April 5, 2023
Clinical applicability of miR517a detection in liquid biopsies of ETMR patientsSibylle Madlener, Julia Furtner, Natalia Stepien, et al.
Cancers|February 5, 2021
Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System LymphomaJulia Furtner, Karl-Heinz Nenning, Thomas Roetzer, et al.
Neuro-Oncology Practice|July 15, 2024
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectivesFlorien Boele, Lena Rosenlund, Sara Nordentoft, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
Neuroimage. Clinical|September 25, 2020
High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSIGilbert Hangel, Cornelius Cadrien, Philipp Lazen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2024
Corrigendum to "Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial" [Eur J Cancer 198 (2024) 113475]Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patientsAngelika M Starzer, Anna S Berghoff, Rainer Hamacher, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Cancers|May 13, 2023
Proof-of-Concept for Liquid Biopsy Disease Monitoring of <i>MYC</i>-Amplified Group 3 Medulloblastoma by Droplet Digital PCRNatalia Stepien, Daniel Senfter, Julia Furtner, et al.
Acta Neuropathologica|April 5, 2023
Clinical applicability of miR517a detection in liquid biopsies of ETMR patientsSibylle Madlener, Julia Furtner, Natalia Stepien, et al.
Cancers|February 5, 2021
Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System LymphomaJulia Furtner, Karl-Heinz Nenning, Thomas Roetzer, et al.
Neuro-Oncology Practice|July 15, 2024
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectivesFlorien Boele, Lena Rosenlund, Sara Nordentoft, et al.
Pageof 15